Evidence check: Stuhlprobe in the context of menopause

The question of a stool test in the context of menopause is understandable, as menopause affects the entire body, including the gut microbiome. However, the scientific evidence for the benefit of stool analysis in this context is weak. Existing studies show correlations between estrogen decline and changes in gut flora, but no validated biomarkers that enable clinical decisions. MyBody-X offers microbiome tests, but according to the context these are classified as “marketing” and lack diagnostic maturity for menopause-specific statements. A stool sample can provide rough hints of dysbiosis but does not replace medical evaluation of symptoms like hot flashes, sleep disturbances, or bone health. The evidence is rated as 'unclear' due to a lack of large, reproducible studies. Caution: Do not initiate hormone therapy or supplementation based solely on a stool test.